4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-004669
Options or other derivatives
- Chief Medical Officer acquired 110,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Katz Barrett Chief Medical Officer | 2022-02-02 | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | D | ||
Loading xslF345X03/doc4.xml…